- Report
- March 2024
- 183 Pages
Global
From €3270EUR$3,374USD£2,801GBP
€3633EUR$3,749USD£3,112GBP
- Report
- February 2024
- 175 Pages
Global
From €4846EUR$5,000USD£4,150GBP
- Report
- April 2024
- 194 Pages
Global
From €4797EUR$4,950USD£4,109GBP
- Report
- October 2023
- 181 Pages
Global
From €4749EUR$4,900USD£4,067GBP
- Report
- February 2024
- 100 Pages
Global
From €4603EUR$4,750USD£3,943GBP
- Report
- October 2023
- 180 Pages
Global
From €4749EUR$4,900USD£4,067GBP
- Report
- May 2023
- 211 Pages
Global
From €3087EUR$3,185USD£2,644GBP
€4410EUR$4,550USD£3,777GBP
- Report
- May 2023
- 211 Pages
Global
From €3087EUR$3,185USD£2,644GBP
€4410EUR$4,550USD£3,777GBP
- Report
- November 2023
- 198 Pages
Global
€4841EUR$4,995USD£4,146GBP
- Report
- April 2018
- 39 Pages
Global
From €4797EUR$4,950USD£4,109GBP
- Report
- October 2021
- 178 Pages
Global
From €3087EUR$3,185USD£2,644GBP
€4410EUR$4,550USD£3,777GBP
- Report
- February 2022
- 120 Pages
Global
From €2423EUR$2,500USD£2,075GBP
- Report
- September 2020
- 106 Pages
Global
From €4361EUR$4,500USD£3,735GBP
The Human Liver Model market is a subset of the Clinical Trials market, focused on the development of in vitro models of the human liver. These models are used to study the effects of drugs and other compounds on the liver, and to predict the safety and efficacy of drugs in humans. The models are typically composed of human liver cells, and can be used to study the metabolism, toxicity, and pharmacokinetics of drugs. The models are also used to study the effects of genetic and environmental factors on the liver.
The Human Liver Model market is growing due to the increasing demand for in vitro models for drug development and safety testing. The models are also being used to study the effects of diseases on the liver, such as hepatitis and cirrhosis.
Companies in the Human Liver Model market include InSphero, Hepregen, and Emulate. Show Less Read more